Activist investor Starboard cries foul play in exec U-turn at Pfizer
Starboard has accused Pfizer of “coercive conduct” after executives who initially backed the hedge fund retracted their support.
Investment
Activist investor Starboard forges $1bn stake in Pfizer to swing profits
Investors anticipate “bounce-back” in European private investment
Investors grapple with more choices in big year for pharma fundraising
Difficult biotech investment ecosystem forces focus on value
Signal: Dutch health investor Gilde raises $804m for health startup fund
BIO-Europe 2023: Pharma balances on shaky financial and legislative footing
M&A market performance suffered in Q3 2023
